Request for Covid-19 Impact Assessment of this Report
The United States Pegfilgrastim market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pegfilgrastim market, reaching US$ million by the year 2028. As for the Europe Pegfilgrastim landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pegfilgrastim players cover Amgen, Mylan, Coherus BioSciences, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pegfilgrastim market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Pegfilgrastim
Pegfilgrastim Biosimilar
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drug store
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Amgen
Mylan
Coherus BioSciences
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pegfilgrastim Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pegfilgrastim by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pegfilgrastim by Country/Region, 2017, 2022 & 2028
2.2 Pegfilgrastim Segment by Type
2.2.1 Pegfilgrastim
2.2.2 Pegfilgrastim Biosimilar
2.3 Pegfilgrastim Sales by Type
2.3.1 Global Pegfilgrastim Sales Market Share by Type (2017-2022)
2.3.2 Global Pegfilgrastim Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pegfilgrastim Sale Price by Type (2017-2022)
2.4 Pegfilgrastim Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Pegfilgrastim Sales by Application
2.5.1 Global Pegfilgrastim Sale Market Share by Application (2017-2022)
2.5.2 Global Pegfilgrastim Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pegfilgrastim Sale Price by Application (2017-2022)
3 Global Pegfilgrastim by Company
3.1 Global Pegfilgrastim Breakdown Data by Company
3.1.1 Global Pegfilgrastim Annual Sales by Company (2020-2022)
3.1.2 Global Pegfilgrastim Sales Market Share by Company (2020-2022)
3.2 Global Pegfilgrastim Annual Revenue by Company (2020-2022)
3.2.1 Global Pegfilgrastim Revenue by Company (2020-2022)
3.2.2 Global Pegfilgrastim Revenue Market Share by Company (2020-2022)
3.3 Global Pegfilgrastim Sale Price by Company
3.4 Key Manufacturers Pegfilgrastim Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pegfilgrastim Product Location Distribution
3.4.2 Players Pegfilgrastim Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pegfilgrastim by Geographic Region
4.1 World Historic Pegfilgrastim Market Size by Geographic Region (2017-2022)
4.1.1 Global Pegfilgrastim Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pegfilgrastim Annual Revenue by Geographic Region
4.2 World Historic Pegfilgrastim Market Size by Country/Region (2017-2022)
4.2.1 Global Pegfilgrastim Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pegfilgrastim Annual Revenue by Country/Region
4.3 Americas Pegfilgrastim Sales Growth
4.4 APAC Pegfilgrastim Sales Growth
4.5 Europe Pegfilgrastim Sales Growth
4.6 Middle East & Africa Pegfilgrastim Sales Growth
5 Americas
5.1 Americas Pegfilgrastim Sales by Country
5.1.1 Americas Pegfilgrastim Sales by Country (2017-2022)
5.1.2 Americas Pegfilgrastim Revenue by Country (2017-2022)
5.2 Americas Pegfilgrastim Sales by Type
5.3 Americas Pegfilgrastim Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pegfilgrastim Sales by Region
6.1.1 APAC Pegfilgrastim Sales by Region (2017-2022)
6.1.2 APAC Pegfilgrastim Revenue by Region (2017-2022)
6.2 APAC Pegfilgrastim Sales by Type
6.3 APAC Pegfilgrastim Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pegfilgrastim by Country
7.1.1 Europe Pegfilgrastim Sales by Country (2017-2022)
7.1.2 Europe Pegfilgrastim Revenue by Country (2017-2022)
7.2 Europe Pegfilgrastim Sales by Type
7.3 Europe Pegfilgrastim Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pegfilgrastim by Country
8.1.1 Middle East & Africa Pegfilgrastim Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pegfilgrastim Revenue by Country (2017-2022)
8.2 Middle East & Africa Pegfilgrastim Sales by Type
8.3 Middle East & Africa Pegfilgrastim Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pegfilgrastim
10.3 Manufacturing Process Analysis of Pegfilgrastim
10.4 Industry Chain Structure of Pegfilgrastim
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pegfilgrastim Distributors
11.3 Pegfilgrastim Customer
12 World Forecast Review for Pegfilgrastim by Geographic Region
12.1 Global Pegfilgrastim Market Size Forecast by Region
12.1.1 Global Pegfilgrastim Forecast by Region (2023-2028)
12.1.2 Global Pegfilgrastim Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pegfilgrastim Forecast by Type
12.7 Global Pegfilgrastim Forecast by Application
13 Key Players Analysis
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Pegfilgrastim Product Offered
13.1.3 Amgen Pegfilgrastim Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Pegfilgrastim Product Offered
13.2.3 Mylan Pegfilgrastim Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Coherus BioSciences
13.3.1 Coherus BioSciences Company Information
13.3.2 Coherus BioSciences Pegfilgrastim Product Offered
13.3.3 Coherus BioSciences Pegfilgrastim Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Coherus BioSciences Main Business Overview
13.3.5 Coherus BioSciences Latest Developments
14 Research Findings and Conclusion
Table 1. Pegfilgrastim Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pegfilgrastim Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Pegfilgrastim
Table 4. Major Players of Pegfilgrastim Biosimilar
Table 5. Global Pegfilgrastim Sales by Type (2017-2022) & (K Units)
Table 6. Global Pegfilgrastim Sales Market Share by Type (2017-2022)
Table 7. Global Pegfilgrastim Revenue by Type (2017-2022) & ($ million)
Table 8. Global Pegfilgrastim Revenue Market Share by Type (2017-2022)
Table 9. Global Pegfilgrastim Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Pegfilgrastim Sales by Application (2017-2022) & (K Units)
Table 11. Global Pegfilgrastim Sales Market Share by Application (2017-2022)
Table 12. Global Pegfilgrastim Revenue by Application (2017-2022)
Table 13. Global Pegfilgrastim Revenue Market Share by Application (2017-2022)
Table 14. Global Pegfilgrastim Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Pegfilgrastim Sales by Company (2020-2022) & (K Units)
Table 16. Global Pegfilgrastim Sales Market Share by Company (2020-2022)
Table 17. Global Pegfilgrastim Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Pegfilgrastim Revenue Market Share by Company (2020-2022)
Table 19. Global Pegfilgrastim Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Pegfilgrastim Producing Area Distribution and Sales Area
Table 21. Players Pegfilgrastim Products Offered
Table 22. Pegfilgrastim Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pegfilgrastim Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Pegfilgrastim Sales Market Share Geographic Region (2017-2022)
Table 27. Global Pegfilgrastim Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Pegfilgrastim Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Pegfilgrastim Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Pegfilgrastim Sales Market Share by Country/Region (2017-2022)
Table 31. Global Pegfilgrastim Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Pegfilgrastim Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Pegfilgrastim Sales by Country (2017-2022) & (K Units)
Table 34. Americas Pegfilgrastim Sales Market Share by Country (2017-2022)
Table 35. Americas Pegfilgrastim Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Pegfilgrastim Revenue Market Share by Country (2017-2022)
Table 37. Americas Pegfilgrastim Sales by Type (2017-2022) & (K Units)
Table 38. Americas Pegfilgrastim Sales Market Share by Type (2017-2022)
Table 39. Americas Pegfilgrastim Sales by Application (2017-2022) & (K Units)
Table 40. Americas Pegfilgrastim Sales Market Share by Application (2017-2022)
Table 41. APAC Pegfilgrastim Sales by Region (2017-2022) & (K Units)
Table 42. APAC Pegfilgrastim Sales Market Share by Region (2017-2022)
Table 43. APAC Pegfilgrastim Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Pegfilgrastim Revenue Market Share by Region (2017-2022)
Table 45. APAC Pegfilgrastim Sales by Type (2017-2022) & (K Units)
Table 46. APAC Pegfilgrastim Sales Market Share by Type (2017-2022)
Table 47. APAC Pegfilgrastim Sales by Application (2017-2022) & (K Units)
Table 48. APAC Pegfilgrastim Sales Market Share by Application (2017-2022)
Table 49. Europe Pegfilgrastim Sales by Country (2017-2022) & (K Units)
Table 50. Europe Pegfilgrastim Sales Market Share by Country (2017-2022)
Table 51. Europe Pegfilgrastim Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Pegfilgrastim Revenue Market Share by Country (2017-2022)
Table 53. Europe Pegfilgrastim Sales by Type (2017-2022) & (K Units)
Table 54. Europe Pegfilgrastim Sales Market Share by Type (2017-2022)
Table 55. Europe Pegfilgrastim Sales by Application (2017-2022) & (K Units)
Table 56. Europe Pegfilgrastim Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Pegfilgrastim Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Pegfilgrastim Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Pegfilgrastim Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Pegfilgrastim Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pegfilgrastim Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Pegfilgrastim Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Pegfilgrastim Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Pegfilgrastim Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Pegfilgrastim
Table 66. Key Market Challenges & Risks of Pegfilgrastim
Table 67. Key Industry Trends of Pegfilgrastim
Table 68. Pegfilgrastim Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Pegfilgrastim Distributors List
Table 71. Pegfilgrastim Customer List
Table 72. Global Pegfilgrastim Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Pegfilgrastim Sales Market Forecast by Region
Table 74. Global Pegfilgrastim Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Pegfilgrastim Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Pegfilgrastim Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Pegfilgrastim Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Pegfilgrastim Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Pegfilgrastim Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Pegfilgrastim Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Pegfilgrastim Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Pegfilgrastim Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Pegfilgrastim Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Pegfilgrastim Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Pegfilgrastim Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Pegfilgrastim Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Pegfilgrastim Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Pegfilgrastim Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Pegfilgrastim Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Pegfilgrastim Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Pegfilgrastim Revenue Market Share Forecast by Application (2023-2028)
Table 92. Amgen Basic Information, Pegfilgrastim Manufacturing Base, Sales Area and Its Competitors
Table 93. Amgen Pegfilgrastim Product Offered
Table 94. Amgen Pegfilgrastim Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Amgen Main Business
Table 96. Amgen Latest Developments
Table 97. Mylan Basic Information, Pegfilgrastim Manufacturing Base, Sales Area and Its Competitors
Table 98. Mylan Pegfilgrastim Product Offered
Table 99. Mylan Pegfilgrastim Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Mylan Main Business
Table 101. Mylan Latest Developments
Table 102. Coherus BioSciences Basic Information, Pegfilgrastim Manufacturing Base, Sales Area and Its Competitors
Table 103. Coherus BioSciences Pegfilgrastim Product Offered
Table 104. Coherus BioSciences Pegfilgrastim Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Coherus BioSciences Main Business
Table 106. Coherus BioSciences Latest Developments
List of Figures
Figure 1. Picture of Pegfilgrastim
Figure 2. Pegfilgrastim Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pegfilgrastim Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pegfilgrastim Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pegfilgrastim Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Pegfilgrastim
Figure 10. Product Picture of Pegfilgrastim Biosimilar
Figure 11. Global Pegfilgrastim Sales Market Share by Type in 2021
Figure 12. Global Pegfilgrastim Revenue Market Share by Type (2017-2022)
Figure 13. Pegfilgrastim Consumed in Hospital
Figure 14. Global Pegfilgrastim Market: Hospital (2017-2022) & (K Units)
Figure 15. Pegfilgrastim Consumed in Drug store
Figure 16. Global Pegfilgrastim Market: Drug store (2017-2022) & (K Units)
Figure 17. Global Pegfilgrastim Sales Market Share by Application (2017-2022)
Figure 18. Global Pegfilgrastim Revenue Market Share by Application in 2021
Figure 19. Pegfilgrastim Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Pegfilgrastim Revenue Market Share by Company in 2021
Figure 21. Global Pegfilgrastim Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Pegfilgrastim Revenue Market Share by Geographic Region in 2021
Figure 23. Global Pegfilgrastim Sales Market Share by Region (2017-2022)
Figure 24. Global Pegfilgrastim Revenue Market Share by Country/Region in 2021
Figure 25. Americas Pegfilgrastim Sales 2017-2022 (K Units)
Figure 26. Americas Pegfilgrastim Revenue 2017-2022 ($ Millions)
Figure 27. APAC Pegfilgrastim Sales 2017-2022 (K Units)
Figure 28. APAC Pegfilgrastim Revenue 2017-2022 ($ Millions)
Figure 29. Europe Pegfilgrastim Sales 2017-2022 (K Units)
Figure 30. Europe Pegfilgrastim Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Pegfilgrastim Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Pegfilgrastim Revenue 2017-2022 ($ Millions)
Figure 33. Americas Pegfilgrastim Sales Market Share by Country in 2021
Figure 34. Americas Pegfilgrastim Revenue Market Share by Country in 2021
Figure 35. United States Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Pegfilgrastim Sales Market Share by Region in 2021
Figure 40. APAC Pegfilgrastim Revenue Market Share by Regions in 2021
Figure 41. China Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Pegfilgrastim Sales Market Share by Country in 2021
Figure 48. Europe Pegfilgrastim Revenue Market Share by Country in 2021
Figure 49. Germany Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Pegfilgrastim Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Pegfilgrastim Revenue Market Share by Country in 2021
Figure 56. Egypt Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Pegfilgrastim Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Pegfilgrastim in 2021
Figure 62. Manufacturing Process Analysis of Pegfilgrastim
Figure 63. Industry Chain Structure of Pegfilgrastim
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...